TG THERAPEUTICS INC (TGTX:NASDAQ)
$56.44 1.65 (3.0115%)
Analysed TG THERAPEUTICS INC (TGTX:NASDAQ) News Sources
Henry Schein to Report Q3 Earnings: Here's What You Should Know
27-10-2026
yahoo.com
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
27-10-2026
yahoo.com
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
27-10-2026
yahoo.com
Stocktwits Pharma Pulse: Moderna-Merck Cancer Vaccine Grabs Spotlight As Kidney-Cancer And MS Data Pour In
19-10-2026
stocktwits.com
TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026
21-10-2026
yahoo.com
TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026
23-10-2026
yahoo.com
TGTX Stock Bucks Broader Biotech Selloff As Multiple Sclerosis Therapy Shows Promising Early Results — Here’s What Investors Need To Know
23-10-2026
stocktwits.com
How Investors Are Reacting To TG Therapeutics (TGTX) Early MS Cell Therapy Data
27-10-2026
yahoo.com
TG Therapeutics (TGTX) Stock May Be Underpriced Relative To Earnings
27-10-2026
yahoo.com
Why TG Therapeutics (TGTX) Shares Climbed After Its Latest Update
28-10-2026
yahoo.com
What is the current price of TG THERAPEUTICS INC (TGTX:NASDAQ)?
The current price of TG THERAPEUTICS INC (TGTX:NASDAQ) is $56.44.
TG THERAPEUTICS INC (TGTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TG THERAPEUTICS INC (TGTX:NASDAQ) since the previous trading day is $1.65.
TG THERAPEUTICS INC (TGTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TG THERAPEUTICS INC (TGTX:NASDAQ) since the previous trading day is 3.0115%.
What is the most recent average sentiment score for TG THERAPEUTICS INC (TGTX:NASDAQ)?
The most recent average sentiment score for TG THERAPEUTICS INC (TGTX:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for TG THERAPEUTICS INC (TGTX:NASDAQ)?
The most recent sentiment for TG THERAPEUTICS INC (TGTX:NASDAQ) is .
SEC-8K** Filing Available For TG THERAPEUTICS INC (TGTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.